[go: up one dir, main page]

SE0302573D0 - Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof - Google Patents

Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Info

Publication number
SE0302573D0
SE0302573D0 SE0302573A SE0302573A SE0302573D0 SE 0302573 D0 SE0302573 D0 SE 0302573D0 SE 0302573 A SE0302573 A SE 0302573A SE 0302573 A SE0302573 A SE 0302573A SE 0302573 D0 SE0302573 D0 SE 0302573D0
Authority
SE
Sweden
Prior art keywords
sup
preparation
compositions containing
benzimidazole derivatives
compounds
Prior art date
Application number
SE0302573A
Other languages
English (en)
Inventor
Ziping Liu
Daniel Page
Christopher Walpole
Hua Yang
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302573A priority Critical patent/SE0302573D0/sv
Publication of SE0302573D0 publication Critical patent/SE0302573D0/sv
Priority to EP04768667A priority patent/EP1670769B1/en
Priority to US10/573,054 priority patent/US8633235B2/en
Priority to NZ545736A priority patent/NZ545736A/en
Priority to UY28536A priority patent/UY28536A1/es
Priority to JP2006527490A priority patent/JP4896721B2/ja
Priority to PL04768667T priority patent/PL1670769T3/pl
Priority to CN2010105277900A priority patent/CN102010373A/zh
Priority to SI200431166T priority patent/SI1670769T1/sl
Priority to KR1020067005825A priority patent/KR101170184B1/ko
Priority to RU2006113371/04A priority patent/RU2346938C2/ru
Priority to DK04768667T priority patent/DK1670769T3/da
Priority to PT04768667T priority patent/PT1670769E/pt
Priority to MXPA06003197A priority patent/MXPA06003197A/es
Priority to CA2539738A priority patent/CA2539738C/en
Priority to CNA2004800350086A priority patent/CN1886379A/zh
Priority to ARP040103467A priority patent/AR045819A1/es
Priority to PCT/GB2004/004124 priority patent/WO2005030732A1/en
Priority to AT04768667T priority patent/ATE430135T1/de
Priority to TW093129150A priority patent/TW200521117A/zh
Priority to DE602004020907T priority patent/DE602004020907D1/de
Priority to AU2004276062A priority patent/AU2004276062B2/en
Priority to ES04768667T priority patent/ES2324669T3/es
Priority to MYPI20043910A priority patent/MY140630A/en
Priority to BRPI0414780A priority patent/BRPI0414780B8/pt
Priority to UAA200602693A priority patent/UA86776C2/ru
Priority to SA04250310A priority patent/SA04250310B1/ar
Priority to IL174215A priority patent/IL174215A0/en
Priority to CO06028452A priority patent/CO5680443A2/es
Priority to ZA200602446A priority patent/ZA200602446B/en
Priority to IS8422A priority patent/IS8422A/is
Priority to NO20061839A priority patent/NO20061839L/no
Priority to HK06109758.7A priority patent/HK1089436A1/xx
Priority to ZA200702131A priority patent/ZA200702131B/xx
Priority to ZA200702226A priority patent/ZA200702226B/xx
Priority to HR20090388T priority patent/HRP20090388T1/xx
Priority to CY20091100725T priority patent/CY1110332T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0302573A 2003-09-26 2003-09-26 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof SE0302573D0 (sv)

Priority Applications (37)

Application Number Priority Date Filing Date Title
SE0302573A SE0302573D0 (sv) 2003-09-26 2003-09-26 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW093129150A TW200521117A (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ARP040103467A AR045819A1 (es) 2003-09-26 2004-09-24 Derivados de benzimidazol composiciones que los contienen, preparacion de los mismos y usos de los mismos
US10/573,054 US8633235B2 (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NZ545736A NZ545736A (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UY28536A UY28536A1 (es) 2003-09-26 2004-09-24 Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
JP2006527490A JP4896721B2 (ja) 2003-09-26 2004-09-24 ベンゾイミダゾール誘導体、それを含む組成物、その製造方法およびその使用
PL04768667T PL1670769T3 (pl) 2003-09-26 2004-09-24 Pochodne benzimidazolu, kompozycje zawierające te związki, ich wytwarzanie i zastosowanie
CN2010105277900A CN102010373A (zh) 2003-09-26 2004-09-24 苯并咪唑衍生物、含它们的组合物、其制备方法和用途
SI200431166T SI1670769T1 (sl) 2003-09-26 2004-09-24 Benzimidazolni derivati, sestavki, ki jih vsebujejo, njihova priprava in njihove uporabe
KR1020067005825A KR101170184B1 (ko) 2003-09-26 2004-09-24 벤즈이미다졸 유도체, 그를 포함하는 조성물, 및 그의 제조방법 및 그의 용도
RU2006113371/04A RU2346938C2 (ru) 2003-09-26 2004-09-24 Производные бензимидазола, содержащие их композиции, их получение и применение
DK04768667T DK1670769T3 (da) 2003-09-26 2004-09-24 Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
PT04768667T PT1670769E (pt) 2003-09-26 2004-09-24 Derivados de benzimidazole, composições que os contêm, suas preparações e suas utilizações
MXPA06003197A MXPA06003197A (es) 2003-09-26 2004-09-24 Derivados de bencimidazol, composiciones que los contienen, preparacion de los mismos y usos de los mismos.
CA2539738A CA2539738C (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CNA2004800350086A CN1886379A (zh) 2003-09-26 2004-09-24 苯并咪唑衍生物、含它们的组合物、其制备方法和用途
EP04768667A EP1670769B1 (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AT04768667T ATE430135T1 (de) 2003-09-26 2004-09-24 Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
PCT/GB2004/004124 WO2005030732A1 (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UAA200602693A UA86776C2 (ru) 2003-09-26 2004-09-24 Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
DE602004020907T DE602004020907D1 (de) 2003-09-26 2004-09-24 Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
AU2004276062A AU2004276062B2 (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ES04768667T ES2324669T3 (es) 2003-09-26 2004-09-24 Derivados de bencimidazol, composiciones que los contienen, su preparacion y sus usos.
MYPI20043910A MY140630A (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BRPI0414780A BRPI0414780B8 (pt) 2003-09-26 2004-09-24 composto, uso do mesmo, composição farmacêutica, e, método para preparar um composto
SA04250310A SA04250310B1 (ar) 2003-09-26 2004-09-26 مشتقات بنز إميدازول ، وتركيب تحتوي عليها وتحضيرها واستخداماتها
IL174215A IL174215A0 (en) 2003-09-26 2006-03-09 Benzimidazole derivatives, compositions containing them preparation thereof and uses thereof
CO06028452A CO5680443A2 (es) 2003-09-26 2006-03-22 Derivados de bencimidazol, composiciones que los contienen, preparacion de los mismos y usos de los mismos
ZA200602446A ZA200602446B (en) 2003-09-26 2006-03-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IS8422A IS8422A (is) 2003-09-26 2006-04-21 Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra
NO20061839A NO20061839L (no) 2003-09-26 2006-04-26 Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
HK06109758.7A HK1089436A1 (en) 2003-09-26 2006-09-01 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ZA200702131A ZA200702131B (en) 2003-09-26 2007-03-13 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof l
ZA200702226A ZA200702226B (en) 2003-09-26 2007-03-16 Compounds, compositions containing them, preparations thereof and uses thereof II
HR20090388T HRP20090388T1 (en) 2003-09-26 2009-07-07 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CY20091100725T CY1110332T1 (el) 2003-09-26 2009-07-08 Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302573A SE0302573D0 (sv) 2003-09-26 2003-09-26 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Publications (1)

Publication Number Publication Date
SE0302573D0 true SE0302573D0 (sv) 2003-09-26

Family

ID=29246982

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302573A SE0302573D0 (sv) 2003-09-26 2003-09-26 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Country Status (34)

Country Link
US (1) US8633235B2 (sv)
EP (1) EP1670769B1 (sv)
JP (1) JP4896721B2 (sv)
KR (1) KR101170184B1 (sv)
CN (2) CN102010373A (sv)
AR (1) AR045819A1 (sv)
AT (1) ATE430135T1 (sv)
AU (1) AU2004276062B2 (sv)
BR (1) BRPI0414780B8 (sv)
CA (1) CA2539738C (sv)
CO (1) CO5680443A2 (sv)
CY (1) CY1110332T1 (sv)
DE (1) DE602004020907D1 (sv)
DK (1) DK1670769T3 (sv)
ES (1) ES2324669T3 (sv)
HK (1) HK1089436A1 (sv)
HR (1) HRP20090388T1 (sv)
IL (1) IL174215A0 (sv)
IS (1) IS8422A (sv)
MX (1) MXPA06003197A (sv)
MY (1) MY140630A (sv)
NO (1) NO20061839L (sv)
NZ (1) NZ545736A (sv)
PL (1) PL1670769T3 (sv)
PT (1) PT1670769E (sv)
RU (1) RU2346938C2 (sv)
SA (1) SA04250310B1 (sv)
SE (1) SE0302573D0 (sv)
SI (1) SI1670769T1 (sv)
TW (1) TW200521117A (sv)
UA (1) UA86776C2 (sv)
UY (1) UY28536A1 (sv)
WO (1) WO2005030732A1 (sv)
ZA (3) ZA200602446B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003257145B2 (en) 2002-08-02 2008-11-13 Merck Sharp & Dohme Corp. Substituted furo (2,3-b) pyridine derivatives
SE0302573D0 (sv) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CN101031563A (zh) * 2004-09-24 2007-09-05 阿斯利康(瑞典)有限公司 苯并咪唑衍生物、含有它们的组合物、其制备方法和用途
JP2008514592A (ja) * 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体、それらを含有する組成物、それらの製造及びそれらの使用ｉｉｉ
KR101269869B1 (ko) 2004-09-24 2013-06-07 네오메드 인스티튜트 벤즈이미다졸 유도체, 그를 함유하는 조성물, 그의 제조방법 및 그의 용도
JP5053092B2 (ja) * 2004-09-24 2012-10-17 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体、それを含む組成物、その製造方法及びその使用ｉ
ATE417830T1 (de) 2004-11-02 2009-01-15 Pfizer Sulfonylbenzimidazolderivate
WO2007013848A1 (en) * 2005-07-29 2007-02-01 Astrazeneca Ab Process for the preparation of geminal ((difluorocycloalkyl)methyl) amines.
TW200745049A (en) 2006-03-23 2007-12-16 Astrazeneca Ab New crystalline forms
TW200808769A (en) * 2006-04-18 2008-02-16 Astrazeneca Ab Therapeutic compounds
US20080139846A1 (en) * 2006-09-01 2008-06-12 Astrazeneca Ab New Process 298
US8236841B2 (en) * 2006-09-13 2012-08-07 Kyowa Hakko Kirin Co., Ltd. Fused heterocycle derivative
US20110086853A1 (en) * 2009-10-08 2011-04-14 William Brown Therapeutic Compounds
RU2454234C1 (ru) * 2011-03-16 2012-06-27 Константин Михайлович Аверин Соли 1,3-диэтилбензимидазолия - иммуностимулирующие средства и фармацевтические композиции на их основе
CN104755470B (zh) * 2012-06-13 2019-11-08 塞特克技术公司 含有经取代的苯并二氢吡喃化合物的稳定剂组合物及其使用方法
JP6181172B2 (ja) 2012-06-26 2017-08-16 バイエル・ファルマ・アクティエンゲゼルシャフト アンドロゲン受容体拮抗薬としてのｎ−［４−（キノリン−４−イルオキシ）シクロヘキシル（メチル）］（ヘテロ）アリールカルボキサミド類、医薬品としてのその製造および使用
AU2019232437A1 (en) 2018-03-07 2020-10-08 Bayer Aktiengesellschaft Identification and use of ERK5 inhibitors
EP3972963A1 (en) 2019-05-21 2022-03-30 Bayer Aktiengesellschaft Identification and use of kras inhibitors
CN112010789A (zh) * 2019-05-31 2020-12-01 中国科学院上海药物研究所 乙烯基磺酰胺或乙烯基酰胺类化合物及其制备方法和用途
WO2023166450A1 (ko) * 2022-03-04 2023-09-07 삼진제약주식회사 신규한 헤테로 고리 화합물 및 이를 포함하는 약학적 조성물

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604908A (en) 1965-06-24 1971-05-15 Substd benzimidazoles - with anthelmintic,fungicidal activity and some with antiviral and antibacterial activity
FR5354M (sv) 1965-09-10 1967-09-11
US5387600A (en) 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
DE4237617A1 (de) 1992-11-06 1994-05-11 Bayer Ag Verwendung von substituierten Benzimidazolen
DE4237597A1 (de) 1992-11-06 1994-05-11 Bayer Ag Substituierte Benzimidazole
DE4237557A1 (de) 1992-11-06 1994-05-11 Bayer Ag Substituierte Benzimidazole
US6166219A (en) 1995-12-28 2000-12-26 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
US6348032B1 (en) 1998-11-23 2002-02-19 Cell Pathways, Inc. Method of inhibiting neoplastic cells with benzimidazole derivatives
AU6762400A (en) 1999-08-12 2001-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
US6720317B1 (en) 1999-09-17 2004-04-13 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
WO2001019798A2 (en) 1999-09-17 2001-03-22 Cor Therapeutics Inc. INHIBITORS OF FACTOR Xa
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US7115645B2 (en) 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
SK287527B6 (sk) 2000-01-14 2011-01-04 Bayer Schering Pharma Aktiengesellschaft 1,2-Diarylbenzimidazoly a ich farmaceutické použitie
US7329679B2 (en) * 2000-01-27 2008-02-12 Schering Aktiengesellschaft 1,2 Diarylbenzimidazoles and their pharmaceutical use
WO2001064643A2 (en) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
AU2001273040A1 (en) 2000-06-27 2002-01-08 Du Pont Pharmaceuticals Company Factor xa inhibitors
JP2004515496A (ja) 2000-12-07 2004-05-27 アストラゼネカ・アクチエボラーグ ベンズイミダゾール治療剤
SE0101387D0 (sv) * 2001-04-20 2001-04-20 Astrazeneca Ab Novel compounds
EP1403255A4 (en) 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
TW200505902A (en) 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
SE0301701D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301699D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005007625A2 (en) 2003-07-14 2005-01-27 The University Of Tennessee Research Foundation Heterocyclic amides with anti-tuberculosis activity
WO2005021547A2 (en) 2003-08-28 2005-03-10 Pharmaxis Pty Ltd. Heterocyclic cannabinoid cb2 receptor antagonists
SE0302572D0 (sv) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302571D0 (sv) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302573D0 (sv) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1758884A2 (en) 2004-05-20 2007-03-07 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
JP2008503490A (ja) 2004-06-17 2008-02-07 センジェント・セラピューティクス・インコーポレイテッド チロシンホスファターゼの三置換窒素調節物質
HUE041596T2 (hu) 2004-07-30 2019-05-28 Exelixis Inc Pirrol származékok mint gyógyászati szerek
US20060052421A1 (en) 2004-09-09 2006-03-09 Eastman Kodak Company Conjugation agent
EP1797070A1 (en) 2004-09-24 2007-06-20 AstraZeneca AB Compounds, compositions containing them, preparations thereof and uses thereof ii
EP1797076A1 (en) 2004-09-24 2007-06-20 AstraZeneca AB Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP5053092B2 (ja) 2004-09-24 2012-10-17 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体、それを含む組成物、その製造方法及びその使用ｉ
JP2008514594A (ja) 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体及びカンナビノイド受容体リガンドとしてのその使用ｉ
KR101269869B1 (ko) * 2004-09-24 2013-06-07 네오메드 인스티튜트 벤즈이미다졸 유도체, 그를 함유하는 조성물, 그의 제조방법 및 그의 용도
WO2006033629A1 (en) 2004-09-24 2006-03-30 Astrazeneca Ab Benzimidazole derivatives and their use as cannabinoid receptor ligands
JP2008514589A (ja) 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ 化合物、それらを含有する組成物、それらの製造及びそれらの使用ｉｉｉｉ
JP2008514592A (ja) 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体、それらを含有する組成物、それらの製造及びそれらの使用ｉｉｉ
ATE417830T1 (de) 2004-11-02 2009-01-15 Pfizer Sulfonylbenzimidazolderivate
WO2006078941A2 (en) 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof
TW200745049A (en) 2006-03-23 2007-12-16 Astrazeneca Ab New crystalline forms
TW200808769A (en) 2006-04-18 2008-02-16 Astrazeneca Ab Therapeutic compounds
TW200808772A (en) 2006-06-13 2008-02-16 Astrazeneca Ab Therapeutic compounds

Also Published As

Publication number Publication date
UA86776C2 (ru) 2009-05-25
JP4896721B2 (ja) 2012-03-14
DE602004020907D1 (de) 2009-06-10
ZA200702131B (en) 2008-08-27
PL1670769T3 (pl) 2009-09-30
WO2005030732A1 (en) 2005-04-07
AU2004276062A1 (en) 2005-04-07
US20080207612A1 (en) 2008-08-28
RU2006113371A (ru) 2007-11-10
CN102010373A (zh) 2011-04-13
DK1670769T3 (da) 2009-08-10
AR045819A1 (es) 2005-11-16
BRPI0414780A (pt) 2006-11-21
SA04250310B1 (ar) 2009-01-19
IS8422A (is) 2006-04-21
TW200521117A (en) 2005-07-01
KR20070001052A (ko) 2007-01-03
KR101170184B1 (ko) 2012-07-31
CY1110332T1 (el) 2015-01-14
JP2007506721A (ja) 2007-03-22
BRPI0414780B8 (pt) 2021-05-25
MXPA06003197A (es) 2006-06-23
ES2324669T3 (es) 2009-08-12
MY140630A (en) 2010-01-15
ZA200602446B (en) 2007-09-26
US8633235B2 (en) 2014-01-21
CA2539738A1 (en) 2005-04-07
CO5680443A2 (es) 2006-09-29
AU2004276062B2 (en) 2008-05-22
SI1670769T1 (sl) 2009-10-31
ATE430135T1 (de) 2009-05-15
NZ545736A (en) 2009-11-27
CN1886379A (zh) 2006-12-27
BRPI0414780B1 (pt) 2018-10-23
EP1670769B1 (en) 2009-04-29
HRP20090388T1 (en) 2009-08-31
HK1089436A1 (en) 2006-12-01
EP1670769A1 (en) 2006-06-21
CA2539738C (en) 2011-11-22
NO20061839L (no) 2006-06-26
ZA200702226B (en) 2009-01-28
IL174215A0 (en) 2006-08-01
UY28536A1 (es) 2005-04-29
RU2346938C2 (ru) 2009-02-20
PT1670769E (pt) 2009-07-09

Similar Documents

Publication Publication Date Title
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE0401971D0 (sv) Piperidne derivatives
WO2004060882A8 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
SE0401342D0 (sv) Therapeutic compounds
SE9900961D0 (sv) Novel compounds
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0104250D0 (sv) Heterocyclic compounds
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0203303D0 (sv) Novel Compounds
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0203300D0 (sv) Novel Compounds
SE0302571D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
SE0400027D0 (sv) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
UY27587A1 (es) Heterociclos terapéuticos
SE0301445D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300104D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400285D0 (sv) Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
SE0301698D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof